Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry
DOI:
https://doi.org/10.2340/actadv.v103.5331Keywords:
psoriasis, latent class analysis, phenotypes, comorbidities, disease characterizationAbstract
Abstract is missing (Short communication)
Downloads
References
Banfield JD RAE. Model-based Gaussian and non-Gaussian clustering. Biometrics 1993;49:803e21.
https://doi.org/10.2307/2532201 DOI: https://doi.org/10.2307/2532201
Cazzaniga S, Pezzolo E, Bettoli V, Abeni D, Marzano AV, Patrizi A, et al. Characterization of hidradenitis suppurativa phenotypes: a multidimensional latent class analysis of the National Italian Registry IRHIS. J Invest Dermatol 2021; 141: 1236-1242.e1.
https://doi.org/10.1016/j.jid.2020.08.032 DOI: https://doi.org/10.1016/j.jid.2020.08.032
Wu CY, Hu HY, Li CP, Chou YJ, Chang YT. Comorbidity profiles of psoriasis in Taiwan: a latent class analysis. PLoS One 2018; 13: e0192537.
https://doi.org/10.1371/journal.pone.0192537 DOI: https://doi.org/10.1371/journal.pone.0192537
Boeri M, Saure D, Schacht A, Riedl E, Hauber B. Modeling heterogeneity in patients' preferences for psoriasis treatments in a multicountry study: a comparison between random-parameters logit and latent class approaches. Pharmacoeconomics 2020; 38: 593-606.
https://doi.org/10.1007/s40273-020-00894-7 DOI: https://doi.org/10.1007/s40273-020-00894-7
Nielsen ML, Petersen TC, Maul JT, Wu JJ, Rasmussen MK, Bertelsen T, et al. Multivariable predictive models to identify the optimal biologic therapy for treatment of patients with psoriasis at the individual level. JAMA Dermatol 2022; 158: 1149-1156.
https://doi.org/10.1001/jamadermatol.2022.3171 DOI: https://doi.org/10.1001/jamadermatol.2022.3171
Lo Y, Chiu HY, Tsai TF. Clinical features and genetic polymorphism in Chinese patients with erythrodermic psoriasis in a single dermatologic clinic. Mol Diagn Ther 2020; 24: 85-93.
https://doi.org/10.1007/s40291-019-00441-x DOI: https://doi.org/10.1007/s40291-019-00441-x
Ma AR, Liu F, Wang R, Lin L, Wang Y, Li Q, et al. Prevalence of metabolic syndrome in chinese patients with erythrodermic psoriasis: a case-control study. Front Endocrinol (Lausanne) 2021; 12: 677912.
https://doi.org/10.3389/fendo.2021.677912 DOI: https://doi.org/10.3389/fendo.2021.677912
Chiang CY, Tsai TF. Treatment response of patients with erythrodermic psoriasis after switching to guselkumab. Dermatol Ther (Heidelb) 2021; 11: 301-306.
https://doi.org/10.1007/s13555-020-00480-x DOI: https://doi.org/10.1007/s13555-020-00480-x
Alajmi RS, Alamoudi SM, Alabbasi AA, Alwagdani A, Alraddadi AA, Alamri A. Patterns of comorbidities in psoriasis patients: a cross-sectional study. Cureus 2021; 13: e14907.
https://doi.org/10.7759/cureus.14907 DOI: https://doi.org/10.7759/cureus.14907
Naldi L. Psoriasis and smoking: links and risks. Psoriasis (Auckl) 2016; 6: 65-71.
https://doi.org/10.2147/PTT.S85189 DOI: https://doi.org/10.2147/PTT.S85189
Christophers E, Barker JN, Griffiths CE, Dauden E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010; 24: 548-554.
https://doi.org/10.1111/j.1468-3083.2009.03463.x DOI: https://doi.org/10.1111/j.1468-3083.2009.03463.x
Pirro F, Caldarola G, Chiricozzi A, Burlando M, Mariani M, Parodi A, et al. Impact of body mass index on the efficacy of biological therapies in patients with psoriasis: a real-world study. Clin Drug Investig 2021; 41: 917-925.
https://doi.org/10.1007/s40261-021-01080-z DOI: https://doi.org/10.1007/s40261-021-01080-z
Mastorino L, Roccuzzo G, Dapavo P, Siliquini N, Avallone G, Rubatto M, et al. Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population. Br J Dermatol 2022; 187: 263-265.
https://doi.org/10.1111/bjd.21048 DOI: https://doi.org/10.1111/bjd.21048
Miceli A, Schmieder GJ. Palmoplantar Psoriasis. Treasure Island, FL: StatPearls; 2022.
Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csorgo Z, Boonen H, et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol 2020; 34: 2461-2498.
https://doi.org/10.1111/jdv.16915 DOI: https://doi.org/10.1111/jdv.16915
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Simone Cazzaniga, Kristine Heidemeyer, Luigi Naldi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
